Table 4.
CARES Sexual interesta | CARES Sexual dysfunctiona | |||
---|---|---|---|---|
β (se)b | p-value | β (se)b | p-value | |
Treatment-associated amenorrhea | ||||
No amenorrhea/ No chemotherapy | Reference | Reference | ||
Amenorrhea | 0.37 (0.12) | 0.003 | 0.20 (0.16) | 0.21 |
No amenorrhea/Chemotherapy | 0.30 (0.12) | 0.02 | 0.20 (0.16) | 0.23 |
Symptoms | ||||
Vaginal painc | 0.11 (0.04) | 0.002 | 0.62 (0.05) | <0.0001 |
Hot flashes | −0.02 (0.04) | 0.52 | −0.05 (0.05) | 0.28 |
Weight problems | 0.32 (0.05) | <0.0001 | 0.05 (0.06) | 0.47 |
CARES body image | 0.36 (0.04) | <0.0001 | 0.17 (0.05) | 0.002 |
Fatigue | 0.14 (0.09) | 0.12 | 0.35 (0.11) | 0.003 |
Musculoskeletal pain | 0.07 (0.04) | 0.10 | 0.04 (0.05) | 0.43 |
Abbreviations: CARES, Cancer Rehabilitation Evaluation System; se, standard error
Adjusted for stage, age, race/ethnicity, treatment, partner status, time from diagnosis, and all variables included in table.
Positive coefficients with a p-value ≤0.05 are associated with higher CARES scores, which indicates significantly more sexual functioning concerns.
In non-sexually active women, “vaginal pain” includes the single item measuring vaginal dryness severity. In sexually-active women, “vaginal pain” includes items measuring both vaginal dryness and dyspareunia severity.